Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 509 publications

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database.

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database.

Journal: Science progress
Published: October 15, 2025

Rare gliomas: standard treatment approaches and new target therapies.

Rare gliomas: standard treatment approaches and new target therapies.

Journal: Current opinion in neurology
Published: September 24, 2025

The Utility of Tissue-Agnostic Drugs in Lung Cancer Treatment.

The Utility of Tissue-Agnostic Drugs in Lung Cancer Treatment.

Journal: Pharmaceutical medicine
Published: August 26, 2025

Taletrectinib (Ibtrozi) - another kinase inhibitor for non-small cell lung cancer (NSCLC).

Taletrectinib (Ibtrozi) - another kinase inhibitor for non-small cell lung cancer (NSCLC).

Journal: The Medical letter on drugs and therapeutics
Published: July 29, 2025

Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer.

Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer.

Journal: Current oncology (Toronto, Ont.)
Published: July 29, 2025

Development of PROTACs for targeted degradation of oncogenic TRK fusions.

Development of PROTACs for targeted degradation of oncogenic TRK fusions.

Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025

Recent advances in tropomyosin receptor kinase (TRK) inhibitors: a 2023-2024 patent landscape review.

Recent advances in tropomyosin receptor kinase (TRK) inhibitors: a 2023-2024 patent landscape review.

Journal: Expert opinion on therapeutic patents
Published: July 05, 2025

Pulmonary embolism masquerading as ST elevation myocardial infarction and ventricular tachycardia.

Pulmonary embolism masquerading as ST elevation myocardial infarction and ventricular tachycardia.

Journal: BMJ case reports
Published: June 24, 2025

Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviews.

Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviews.

Journal: International journal of technology assessment in health care
Published: June 24, 2025

Toxicity profiles of ROS1 tyrosine kinase inhibitors in advanced non-small cell lung cancer: a systematic review and proportional meta-analysis.

Toxicity profiles of ROS1 tyrosine kinase inhibitors in advanced non-small cell lung cancer: a systematic review and proportional meta-analysis.

Journal: Frontiers in pharmacology
Published: June 09, 2025

Case Report: Metastasis to pleura and mediastinal lymph nodes from breast secretory carcinoma: 10 years follow-up.

Case Report: Metastasis to pleura and mediastinal lymph nodes from breast secretory carcinoma: 10 years follow-up.

Journal: Frontiers in oncology
Published: June 05, 2025

ECMO combined with IABP for the treatment of fulminant myocarditis caused by the targeted drug entrectinib for lung adenocarcinoma: a case report.

ECMO combined with IABP for the treatment of fulminant myocarditis caused by the targeted drug entrectinib for lung adenocarcinoma: a case report.

Journal: Frontiers in cardiovascular medicine
Published: May 10, 2025
Showing 1-12 of 509

Last Updated: 10/31/2025